Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive Approach
| dc.contributor.author | Dirican, Emre | |
| dc.contributor.author | Bal, Tayibe | |
| dc.contributor.author | Önlen, Yusuf | |
| dc.contributor.author | Sarıgül, Figen | |
| dc.contributor.author | Baykam, Nurcan | |
| dc.date.accessioned | 2026-03-31T13:21:21Z | |
| dc.date.available | 2026-03-31T13:21:21Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Aim: This study aimed to determine the important features and cut-off values after demonstrating the detectability of cirrhosis using routine laboratory test results of chronic hepatitis C (CHC) patients in machine learning (ML) algorithms. Methods: This retrospective multicenter (37 referral centers) study included the data obtained from the Hepatitis C Turkey registry of 1164 patients with biopsy-proven CHC. Three different ML algorithms were used to classify the presence/absence of cirrhosis with the determined features. Results: The highest performance in the prediction of cirrhosis (Accuracy = 0.89, AUC = 0.87) was obtained from the Random Forest (RF) method. The five most important features that contributed to the classification were platelet, alpha lpha-feto protein (AFP), age, gamma-glutamyl transferase (GGT), and prothrombin time (PT). The cut-off values of these features were obtained as platelet < 182.000/mm3, AFP > 5.49 ng/mL, age > 52 years, GGT > 39.9 U/L, and PT > 12.35 s. Using cut-off values, the risk coefficients were AOR = 4.82 for platelet, AOR = 3.49 for AFP, AOR = 4.32 for age, AOR = 3.04 for GGT, and AOR = 2.20 for PT. Conclusion: These findings indicated that the RF-based ML algorithm could classify cirrhosis with high accuracy. Thus, crucial features and cut-off values for physicians in the detection of cirrhosis were determined. In addition, although AFP is not included in non-invasive indexes, it had a remarkable contribution in predicting cirrhosis. Trial Registration: Clinicaltrials.gov identifier: NCT03145844 | |
| dc.identifier.doi | 10.1002/jcla.70054 | |
| dc.identifier.issn | 0887-8013 | |
| dc.identifier.issn | 1098-2825 | |
| dc.identifier.issue | 12 | |
| dc.identifier.pmid | 40384539 | |
| dc.identifier.uri | http://dx.doi.org/10.1002/jcla.70054 | |
| dc.identifier.uri | https://hdl.handle.net/11491/9711 | |
| dc.identifier.volume | 39 | |
| dc.identifier.wos | WOS:001490437900001 | |
| dc.language.iso | en | |
| dc.publisher | WILEY | |
| dc.relation.ispartof | J CLIN LAB ANAL | |
| dc.subject | alfa-feto protein | |
| dc.subject | chronic hepatitis C | |
| dc.subject | classification | |
| dc.subject | diagnosis of cirrhosis | |
| dc.subject | machine learning | |
| dc.title | Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive Approach | |
| dc.type | Article |












